Zomedica Corp. (ZOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.1312
-0.0006 (-0.49%)
At close: Feb 27, 2026
Zomedica Employees
Zomedica had 152 employees as of December 31, 2024. The number of employees increased by 8 or 5.56% compared to the previous year.
Employees
152
Change (1Y)
8
Growth (1Y)
5.56%
Revenue / Employee
$193,776
Profits / Employee
-$556,066
Market Cap
128.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 152 | 8 | 5.56% |
| Dec 31, 2023 | 144 | 59 | 69.41% |
| Dec 31, 2022 | 85 | 38 | 80.85% |
| Dec 31, 2021 | 47 | 28 | 147.37% |
| Dec 31, 2020 | 19 | -9 | -32.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PetVivo Holdings | 24 |
| Positron | 10 |
| Tian'an Technology Group | 8 |
| Guided Therapeutics | 4 |
| REMSleep Holdings | 2 |
| OpGen | 1 |
| Vivos | 1 |
Zomedica News
- 1 year ago - Zomedica Corp. Announces Transition to OTCQB Venture Market - Accesswire
- 1 year ago - NYSE American to Commence Delisting Proceedings Against Zomedica Corp. (ZOM) - Business Wire
- 1 year ago - Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET - Accesswire
- 1 year ago - Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters - Accesswire
- 1 year ago - Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis - Accesswire
- 1 year ago - Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - Accesswire
- 1 year ago - Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - Accesswire
- 1 year ago - Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - Accesswire